-
Start Preamble
ACTION:
Notice of registration.
SUMMARY:
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as an importer of schedule I or schedule II controlled substances.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice.
Company FR Docket Published Cody Laboratories, Inc. 83 FR 37524 August 1, 2018. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule II controlled substances to the above listed company.
Start SignatureStart Printed Page 54611End Signature End Supplemental InformationDated: October 11, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23684 Filed 10-29-18; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 10/30/2018
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of registration.
- Document Number:
- 2018-23684
- Pages:
- 54610-54611 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2018-23684.pdf